<--- Back to Details
First PageDocument Content
Health / Non-steroidal anti-inflammatory drugs / Merck / Rofecoxib / Sulfones / Merck & Co. / Cyclooxygenase / Osteoarthritis / Rheumatology / Medicine / COX-2 inhibitors / Chemistry
Date: 2009-04-10 01:52:24
Health
Non-steroidal anti-inflammatory drugs
Merck
Rofecoxib
Sulfones
Merck & Co.
Cyclooxygenase
Osteoarthritis
Rheumatology
Medicine
COX-2 inhibitors
Chemistry

Microsoft Word - Vioxx1October2004.DOC

Add to Reading List

Source URL: www.rheumatology.org.au

Download Document from Source Website

File Size: 40,55 KB

Share Document on Facebook

Similar Documents

DEVELOPMENT OF PHARMACEUTICAL PRODUCTS UTILIZING EXTRUSION TECHNOLOGIES Graciela Terife Senior Scientist, Product Value Enhancement Merck & Co., Summit, NJ

DocID: 1nXt9 - View Document

Vaccines / Mumps / Measles / Rubella / Pediatrics / MMRV vaccine / Varicella vaccine / MMR vaccine / Merck & Co. / Medicine / Vaccination / Health

Title: font: times; size: 18 point; style: plain; justified: center; capitalization: first word and Names only THE CHALLENGE OF DEVELOPING AN MMR­VVV COMBINATION VACCINE Alan R. Shaw, PhD

DocID: 1gGkP - View Document

Allergology / Immune system / Merck KGaA / Merck & Co. / Allergen / Kommanditgesellschaft auf Aktien / Pharmaceutical industry / Allergy / Immunotherapy / Medicine / Immunology / Merck

Your contact News Release Gangolf Schrimpf

DocID: 1aWSz - View Document

Amines / Ethers / Sulfonamides / Glaucoma / Dorzolamide / Timolol / Ocular hypertension / Merck & Co. / Betaxolol / Chemistry / Organic chemistry / Carbonic anhydrase inhibitors

TRUSOPT Ped data PAR

DocID: 1aNXe - View Document

Sulfones / Merck & Co. / Saskatchewan / Pharmaceutical industry / COX-2 inhibitors / Merck / Rofecoxib

CNODES: A Canadian Initiative Samy Suissa Lady Davis Institute, Jewish General Hospital McGill University Montreal, Canada

DocID: 1aAtH - View Document